ACCESS Through OTC Innovation Act
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- House
- Sponsor
- 1
- Latest action
- Dec 18, 2025
What it does
The ACCESS Through OTC Innovation Act would amend the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to use the least burdensome appropriate means when evaluating requests for administrative orders related to over-the-counter monograph drugs. It mandates that the Secretary meet with requestors if published reports are insufficient to support a drug’s safety and effectiveness findings, provide recommendations on necessary evidence or study designs, and document meeting minutes and recommendations in the administrative record. The bill aims to streamline the OTC drug review process while preserving existing safety and effectiveness criteria.
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
Where it goes next
While a bill can still move, the questions are about people and money.